4
Changes in Ownership
BeOne Medicines Ltd. Filed Acc 0001662982-26-000002
Director sold 38,287 shares at an average $349.10 ($13,366,092)
- Director acquired 31,027 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wang Xiaodong · Director
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-08 | Sale : show line 1 in the form 10b5-1 | −1,181 | $345.38 | $407,897 | 6,079 | D |
| 2026-09-08 | Sale : show line 2 in the form 10b5-1 | −2,841 | $346.16 | $983,433 | 3,238 | D |
| 2026-09-08 | Sale : show line 3 in the form 10b5-1 | −1,517 | $347.39 | $526,993 | 1,721 | D |
| 2026-09-08 | Sale : show line 4 in the form 10b5-1 | −1,721 | $348.01 | $598,930 | 0 | D |
| 2026-09-08 | Exercise or conversion : show line 5 in the form 10b5-1 | +31,027 | $36.90 | $1,144,896 | 31,027 | D |
| 2026-09-08 | Sale : show line 6 in the form 10b5-1 | −7,492 | $348.31 | $2,609,573 | 23,535 | D |
| 2026-09-08 | Sale : show line 7 in the form 10b5-1 | −10,688 | $349.28 | $3,733,141 | 12,847 | D |
| 2026-09-08 | Sale : show line 8 in the form 10b5-1 | −6,569 | $350.27 | $2,300,951 | 6,278 | D |
| 2026-09-08 | Sale : show line 9 in the form 10b5-1 | −6,278 | $351.25 | $2,205,174 | 0 | D |
| Open-market sales · 38,287 sh · avg $349.10 · $13,366,092 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-08 | Exercise or conversion : show line 10 in the form 10b5-1 Share Option (Right to Buy) | −403,351 | 1,210,079 | D |
Loading xslF345X06/wk-form4_1789073392.xml…